Inge Holm Lauritzen

Keine laufenden Positionen mehr

57 Jahre

Health Technology

Process Industries

Consumer Services

Profil

Inge Holm Lauritzen worked as the Director of Biopharma Partnering at Novozymes A from 2007 to 2010.
Prior to that, from 1998 to 2007, Lauritzen worked at H.
Lundbeck A as the Head of Strategic Sourcing & Commercialization.
Lauritzen also served as the Vice President of Business Development at Topotarget A from 2010 to 2011.
Lauritzen received an undergraduate degree from the Technical University of Denmark.

Ehemalige bekannte Positionen von Inge Holm Lauritzen

Unternehmen	Position	Ende
Novozymes A/S Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.	Corporate Officer/Principal	01.01.2010
H. LUNDBECK A/S	Corporate Officer/Principal	01.01.2004
TOPOTARGET A/S	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von Inge Holm Lauritzen im Detail an

Ausbildung von Inge Holm Lauritzen

Technical University of Denmark

Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Inge Holm Lauritzen im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	1
H. LUNDBECK A/S	Health Technology

Private Unternehmen	2
Topotarget A/S Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark.	Health Technology
Novozymes A/S Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.	Process Industries